Technical Analysis for GKOS - Glaukos Corporation

Grade Last Price % Change Price Change
C 85.76 2.42% 2.03
GKOS closed up 2.42 percent on Friday, March 5, 2021, on approximately normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down
Historical GKOS trend table...

Date Alert Name Type % Chg
Lower Bollinger Band Walk Weakness 0.00%
Stochastic Reached Oversold Weakness 0.00%
Multiple of Ten Bullish Other 0.00%
Below Lower BB Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Fell Below 50 DMA Bearish 2.42%
Below Lower BB Weakness 2.42%
Down 3 Days in a Row Weakness 2.42%
Lower Bollinger Band Touch Weakness 2.42%
Older End-of-Day Signals for GKOS ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Glaukos Corporation Description

Glaukos Corporation (Glaukos) is an ophthalmic medical technology company. The Company is engaged in the development and commercialization of products and procedures for the treatment of glaucoma. Glaukos has developed the micro-invasive glaucoma surgery (MIGS) for glaucoma treatment. It offers iStent, an MIGS device measuring one millimeter long and 0.33 millimeter wide. MIGS procedures involve the insertion of a micro-scale device from within the eye's anterior chamber through a small corneal incision. Glaukos is also engaged in developing a portfolio of micro-scale injectable therapies, including three pipeline products, namely, the iStent Inject, the iStent Supra and iDose. The iStent Inject includes two stents pre-loaded in an auto-injection inserter. The iStent Supra is designed to access an alternative drainage space within the eye. iDose is an implant that is designed to provide a sustained release of a prostaglandin drug to lower intraocular pressure in glaucoma patients.


Classification

Sector: Healthcare
Industry: Medical Instruments & Supplies
Keywords: Medicine Eye Surgery Medical Technology Ophthalmic Ophthalmology Drainage Glaucoma Blindness Vision Implant Incision Treatment Of Glaucoma Cornea Eye Surgery Intraocular Pressure

Is GKOS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 98.88
52 Week Low 23.31
Average Volume 408,226
200-Day Moving Average 59.15
50-Day Moving Average 86.66
20-Day Moving Average 93.34
10-Day Moving Average 92.41
Average True Range 4.38
ADX 21.01
+DI 14.48
-DI 36.03
Chandelier Exit (Long, 3 ATRs ) 85.73
Chandelier Exit (Short, 3 ATRs ) 92.83
Upper Bollinger Band 100.77
Lower Bollinger Band 85.91
Percent B (%b) -0.01
BandWidth 15.93
MACD Line 0.42
MACD Signal Line 2.00
MACD Histogram -1.5755
Fundamentals Value
Market Cap 3.86 Billion
Num Shares 45 Million
EPS 0.37
Price-to-Earnings (P/E) Ratio 231.78
Price-to-Sales 15.31
Price-to-Book 4.82
PEG Ratio 1.64
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 95.19
Resistance 3 (R3) 94.21 90.09 93.62
Resistance 2 (R2) 90.09 87.69 90.58 93.09
Resistance 1 (R1) 87.92 86.20 89.01 88.90 92.57
Pivot Point 83.80 83.80 84.34 84.29 83.80
Support 1 (S1) 81.64 81.40 82.72 82.62 78.95
Support 2 (S2) 77.52 79.92 78.01 78.43
Support 3 (S3) 75.35 77.52 77.90
Support 4 (S4) 76.33